CARRA MEMBERS WORK TOGETHER TO CAPITALIZE ON OPPORTUNITIES, ACTIVELY DEVELOP A STRUCTURE AND A SCIENTIFIC AGENDA, AND COLLABORATE WITH POTENTIAL FUNDING SOURCES TO CREATE A RESEARCH ALLIANCE THAT BENEFITS OUR PATIENTS. CARRA CONDUCTS COLLABORATIVE RESEARCH TO PREVENT, TREAT AND CURE PEDIATRIC RHEUMATIC DISEASES.
| Year | Revenue | Expenses | Net Assets |
|---|---|---|---|
| 2024 990 - Public charity return Jan 1, 2024 to Dec 31, 2024 | $9,591,717 ↓ | $10,591,561 | $11,698,490 |
| 2023 990 - Public charity return Jan 1, 2023 to Dec 31, 2023 | $10,841,004 ↑ | $11,534,351 | $12,698,334 |
| 2022 990 - Public charity return Jan 1, 2022 to Dec 31, 2022 | $10,561,848 ↑ | $11,144,720 | $13,391,681 |
| 2021 990 - Public charity return Jan 1, 2021 to Dec 31, 2021 | $6,468,070 ↑ | $10,024,485 | $13,974,553 |
| 2020 990 - Public charity return Jan 1, 2020 to Dec 31, 2020 | $5,833,140 ↓ | $8,088,772 | $17,530,968 |
| 2019 990 - Public charity return Jan 1, 2019 to Dec 31, 2019 | $11,029,270 ↑ | $8,415,703 | $19,786,600 |
| 2018 990 - Public charity return Jan 1, 2018 to Dec 31, 2018 | $9,976,474 | $7,876,769 | $17,173,033 |
Sign up free to search 16M+ grants and see similar organizations on every nonprofit profile.
Sign Up FreeNo credit card required.